Leaflet: information for the user
Losartán/Hidroclorotiazida Ababor 100 mg/25 mg film-coated tablets EFG
losartan potassium/hydrochlorothiazide
Read this leaflet carefully before you start taking the medicine, because it contains important information for you.
1. What Losartán/Hidroclorotiazida Ababor is and what it is used for
2. What you need to know before you start taking Losartán/Hidroclorotiazida Ababor
3. How to take Losartán/Hidroclorotiazida Ababor
4. Possible side effects
5. Storage of Losartán/Hidroclorotiazida Ababor
6. Contents of the pack and additional information
Losartán/Hidroclorotiazida Ababor is a combination of an angiotensin II receptor antagonist (losartán) and a diuretic (hidroclorotiazida). Angiotensin II is a substance produced in the body that binds to receptors present in blood vessels, causing them to constrict. This results in an increase in blood pressure. Losartán prevents the binding of angiotensin II to these receptors, causing blood vessels to relax, which in turn reduces blood pressure. Hidroclorotiazida causes the kidneys to eliminate a greater amount of water and salts. This also helps to reduce blood pressure.
Losartán/hidroclorotiazida is indicated for the treatment of essential hypertension (high blood pressure).
Do not take Losartán/Hidroclorotiazida Ababor
Warnings and precautionsConsult your doctor, pharmacist, or nurse before starting to take Losartán/Hidroclorotiazida Ababor.
If you experience a decrease in vision or eye pain, these may be symptoms of fluid accumulation in the vascular layer of the eye (choroidal effusion) or an increase in eye pressure and may occur within a few hours to several weeks after taking Losartán/Hidroclorotiazida Ababor. If left untreated, this can lead to permanent vision loss. You may be at a higher risk of this occurring if you have previously had an allergy to penicillin or sulfonamide.
You should inform your doctor if you think you may be pregnant (or could be). Losartán/Hidroclorotiazida Ababor is not recommended at the beginning of pregnancy, and it should not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used in this stage (see the Pregnancy section).
It is essential that you inform your doctor before taking Losartán/Hidroclorotiazida Ababor:
Your doctor may monitor your renal function, blood pressure, and electrolyte levels in your blood (e.g. potassium) at regular intervals.
See also the information under the heading “Do not take Losartán/Hidroclorotiazida Ababor”
Children and adolescents
There is no experience with the use of Losartán/Hidroclorotiazida Ababor in children. Therefore, Losartán/Hidroclorotiazida Ababor should not be administered to children
Other medicines and Losartán/Hidroclorotiazida Ababor
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine.
.
Diuretics like hydrochlorothiazide in Losartán/Hidroclorotiazida Ababor may interact with other medicines.
Lithium preparations should not be taken with Losartán/Hidroclorotiazida Ababor without close monitoring by your doctor.
You may need to take special precautions (e.g. blood tests) if you are taking other diuretics (“urine-producing tablets”), some laxatives, medicines for gout, heart rhythm-controlling medicines, or diabetes medicines (oral or insulin).
It is also essential that your doctor knows if you are taking:
Your doctor may need to adjust your dose and/or take other precautions:
If you are taking an ACE inhibitor or aliskiren (see also the information under the headings “Do not take Losartán/Hidroclorotiazida Ababor” and “Warnings and precautions”
When taking Losartán/Hidroclorotiazida Ababor, inform your doctor if you are undergoing a radiographic test with a contrast medium containing iodine.
Losartán/Hidroclorotiazida Ababor with food and drinks
It is recommended that you do not drink alcohol while taking these tablets: alcohol and Losartán/Hidroclorotiazida Ababor tablets may increase the effects of each other.
Excessive salt in the diet may counteract the effect of Losartán/Hidroclorotiazida Ababor tablets.
Losartán/Hidroclorotiazida Ababor tablets can be taken with or without food.
You should avoid grapefruit juice while taking Losartán/Hidroclorotiazida Ababor
Pregnancy and breastfeeding
Pregnancy
You should inform your doctor if you think you may be pregnant (or could be). Normally, your doctor will advise you to stop taking Losartán/Hidroclorotiazida Ababor before becoming pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Losartán/Hidroclorotiazida Ababor. Losartán/Hidroclorotiazida Ababor is not recommended during pregnancy, and it should not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used in this stage.
Breastfeeding
Inform your doctor if you are breastfeeding or are about to start breastfeeding. Losartán/Hidroclorotiazida Ababor is not recommended for breastfeeding mothers, and your doctor may choose another treatment if you wish to continue breastfeeding
Use in elderly patients
Losartán/Hidroclorotiazida Ababor acts in the same way and is equally well tolerated by most elderly patients and young adults. Most elderly patients require the same dose as younger patients.
Driving and operating machinery
When starting treatment with this medicine, you should not perform tasks that require special attention (e.g. driving a car or using hazardous machinery) until you know how you tolerate your medicine.
Use in athletes:
This medicine contains hydrochlorothiazide, which may produce a positive result in doping control tests.
Important information about some of the components of Losartán/Hidroclorotiazida Ababor
This medicine contains lactose. If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medicine.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Your doctor will decide on the appropriate dose of losartán/hidroclorotiazida, depending on your condition and if you are taking other medications. It is essential to continue taking losartán/hidroclorotiazida as prescribed by your doctor to maintain consistent blood pressure control.
Hypertension
For most patients with high blood pressure, the usual dose is 1 tablet of losartán/hidroclorotiazida 50 mg/12.5 mg per day to control blood pressure for 24 hours. It can be increased to 2 tablets of losartán/hidroclorotiazida 50 mg/12.5 mg per day or changed to 1 tablet of losartán/hidroclorotiazida 100 mg/25 mg (a higher dose) per day. The maximum daily dose is 2 tablets of 50 mg losartán/12.5 mg hidroclorotiazida per day or 1 tablet of 100 mg losartán/25 mg hidroclorotiazida per day.
Administration
The tablets should be swallowed whole with a glass of water.
If you take more Losartán/Hidroclorotiazida Ababor than you should
In case of an overdose, contact your doctor immediately for immediate medical attention.
.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested. It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
An overdose may cause a drop in blood pressure, palpitations, slow pulse, changes in blood composition, and dehydration.
If you forgot to take Losartán/Hidroclorotiazida Ababor
Try to take losartán/hidroclorotiazida every day as prescribed. However, if you forget a dose, do not take a double dose to compensate for the missed dose. The next day, take your usual amount of medication at the usual time.
.
If you experience any of the following, stop taking Losartán/Hidroclorotiazida Ababor tablets and inform your doctor immediately or go to the nearest hospital emergency department:
Severe allergic reaction (skin rash, itching, swelling of the face, lips, mouth, or throat that may cause difficulty swallowing or breathing).
This is a serious but rare side effect that affects more than 1 in 10,000 patients but less than 1 in 1,000. You may need urgent medical attention or hospitalization.
Rare (may affect up to 1 in 10,000 people):
Acute respiratory distress (symptoms include severe difficulty breathing, fever, weakness, and confusion).
Other side effects that may occur:
Frequent (may affect up to 1 in 10 people):
• cough, upper respiratory tract infection, nasal congestion, sinusitis, breast tenderness,
• diarrhea, abdominal pain, nausea, indigestion,
• muscle pain or cramps, leg pain, back pain,
• insomnia, headache, dizziness,
• weakness, fatigue, chest pain,
• elevated potassium levels (which may cause abnormal heart rhythms), decreased
hemoglobin levels.
changes in renal function that include renal insufficiency
• hypoglycemia (low blood sugar).
Occasional (may affect up to 1 in 100 people):
• anemia, red or brown spots on the skin (sometimes especially on the feet, legs, arms, and buttocks, with joint pain, swelling of the hands and feet, and abdominal pain), hematoma, reduced white blood cell count, coagulation problems, reduced platelet count,
,
• loss of appetite, elevated uric acid levels or gout, elevated blood glucose levels, abnormal electrolyte levels in the blood,
• anxiety, nervousness, panic attacks (recurring panic attacks), confusion,
depression, abnormal dreams, sleep disorders, drowsiness, memory alteration,
• tingling or similar sensations, pain in the extremities, tremors, migraine, fainting,
• blurred vision, eye itching or stinging, conjunctivitis, worsening vision, seeing things in yellow
• ringing, buzzing, noises, or crackling in the ears, vertigo
• low blood pressure that may be associated with changes in posture (feeling dizzy or
weak when standing up), angina (chest pain), abnormal heartbeats, transient ischemic attack (TIA), "mini stroke," heart attack, palpitations.
,
• inflammation of blood vessels that often occurs with a skin rash or
hematoma,
• throat pain, shortness of breath, bronchitis, pneumonia, fluid in the lungs (which
causes difficulty breathing), nasal bleeding, runny nose, congestion,
• constipation, chronic constipation, gas, stomach disorders, stomach spasms, vomiting, dry mouth,
salivary gland inflammation, tooth pain,
• jaundice (yellow discoloration of the eyes and skin), pancreatitis,
• urticaria, itching, skin inflammation, skin rash, skin redness, sensitivity to light, dry skin, flushing, sweating, hair loss,
• pain in the arms, shoulders, hips, knees, or other joints, joint swelling, stiffness, muscle weakness,
• frequent urination even at night, abnormal renal function that includes kidney inflammation, urinary tract infection, sugar in the urine
• decreased libido, impotence,
• facial swelling,localized swelling (edema),fever.
Rare (may affect up to 1 in 1,000 people)
• hepatitis (liver inflammation), abnormal liver function tests.
• intestinal angioedema: swelling in the intestine that presents symptoms such as abdominal pain, nausea, vomiting, and diarrhea.
Unknown (frequency cannot be estimated from available data)
• symptoms similar to the flu;
• muscle pain of unknown origin with dark-colored urine (tea-colored urine) (rhabdomyolysis);
• low sodium levels in the blood (hyponatremia);
• generally feeling unwell (malaise);
• altered taste (dysgeusia);
• skin cancer and lip cancer (non-melanoma skin cancer).
• decreased vision or eye pain due to high pressure (possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma).
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging, after CAD. The expiration date is the last day of the month indicated.
Conserve this medication in the original packaging.
Keep the blister in the outer packaging. Do not open the blister until ready to take the tablet.
Medicines should not be thrown down the drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Losartán/Hidroclorotiazida Ababor 100 mg/25 mg
Each tablet of Losartán/Hidroclorotiazida Ababor 100 mg/25 mg contains 8.48 mg (0.216 mEq) of potassium.
Appearance of the product and content of the packaging
Yellow-coated, round tablets.
PVC blister in packs of 28 tablets
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Ababor Pharmaceuticals, S.L.
C/ Chile nº4,Edif 1,Ofic 1,Las Matas,
Las Rozas(28290)Madrid- Spain
Responsible for manufacturing
Sofarimex
Av. Indústrias, Alto do Colaride
Agualva 2735-213 Cacém– Portugal
Ó
Industria Química y Farmacéutica VIR, S.A
C/Laguna 66-70.Polígono Industrial Urtinsa II
28923 Alcorcón (Madrid)
Spain
This leaflet has been revised in: February 2025
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.